期刊
HUMAN MOLECULAR GENETICS
卷 16, 期 -, 页码 R226-R232出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddm184
关键词
-
资金
- NCI NIH HHS [1-R01-CA106520-03, 5-U54-CA112952-03] Funding Source: Medline
Numerous recent studies have demonstrated the use of genomic data, particularly gene expression signatures, as clinical prognostic factors in cancer and other complex diseases. These studies highlight the opportunity for strategies to achieve truly personalized cancer treatment. In particular, the ability to develop gene expression signatures will likely allow us to guide the use of currently available cancer drugs, develop new targeted therapeutics, and provide an opportunity to better match the most effective drug or drugs with the molecular characteristics of the individual patient.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据